EMMA Intrinsic Valuation and Fundamental Analysis - Emmaus Life Sciences Inc

Watchlist Manager

Watchlist

Price: 0.0584 USD 36.45% Market Closed

Market Cap: $4.1m

	Emmaus Life Sciences Inc OTC:EMMA	US
E	Evonik Industries AG F:EVK	DE
	Fortis Frontier PLC F:0I10	UK
A	Aditya Infotech Ltd NSE:CPPLUS	IN
H	Huntsman Corp XMUN:HTR	US

Intrinsic Value

EMMA doesn't have a meaningful market cap.

Is EMMA undervalued or overvalued?

See the intrinsic value estimate for Emmaus Life Sciences Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

EMMA Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with EMMA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price $0.06

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Emmaus Life Sciences Does

Pharmaceuticals Health Care

Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. The company is headquartered in Torrance, California and currently employs 32 full-time employees. The company went IPO on 2000-05-09. The firm is engaged in the discovery, development, marketing and sales of treatments and therapies, primarily for rare and orphan diseases.

Headquarters: United States of America US
Employees: 32
IPO date: May 9, 2000